Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the <i>Fmr1</i>-KO Mouse Model of Fragile X Syndrome

Phytocannabinoids, including the non-addictive cannabis component cannabidivarin (CBDV), have been reported to hold therapeutic potential in several neurodevelopmental disorders (NDDs). Nonetheless, the therapeutic value of phytocannabinoids for treating Fragile X syndrome (FXS), a major NDD, remain...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Marika Premoli, William Fyke, Luigi Bellocchio, Valerie Lemaire, Marie Wolley-Roberts, Bruno Bontempi, Susanna Pietropaolo
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Subjects:	phytocannabinoids <i>Fmr1</i> mouse behavior neurodevelopmental disorders interleukins neurotrophins
Online Access:	https://www.mdpi.com/2073-4409/12/15/1927